Continue reading here:
Notice of Extraordinary General Meeting in Immunicum AB (publ)
- Novan to Present at the Virtual Investor KOL Roundtable [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360° [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™ [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Telo Genomics Announces Warrant Exercise Agreement [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- The Quest for Blockbuster Drugs Continues [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- SCYNEXIS to Present Data Supporting the Efficacy of Ibrexafungerp Against Invasive Fungal Infections at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Radius Health, Inc.: Progress Since May 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Immutep Granted European Patent for IMP761 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- AzurRx BioPharma Announces Formation of Scientific Advisory Board [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Turning Point Therapeutics Announces Abstract For TRIDENT-1 Clinical Study of Repotrectinib Accepted For Presentation at World Conference on Lung... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™ [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business... [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2020]
- XORTX Participation in Virtual Conferences [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Zenith Confirms Interim Filings on SEDAR [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Trading by management and close relations of management [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- AXIM® Biotechnologies Issues Update Letter to Shareholders [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Scout Bio Advances Novel Gene Therapy for the Treatment of Feline Diabetes [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Kane Biotech builds upon successful results with launch of a US Consumer Test [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November 5th [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- BetterLife Provides Important Update on its Australian Clinical Study Design [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Iovance Biotherapeutics to Present at Upcoming Conferences in November [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Verona Pharma plc : Update on AIM Delisting [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Nobilis Therapeutics to Present at CapCon 2020 Venture Conference [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Generex Subsidiary NuGenerex Immuno-Oncology Announces Appointment of Dr. Tamera Coyne-Beasley to the Scientific Advisory Board for its COVID-19... [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- BioVie Interview to Air on Bloomberg International on the RedChip Money Report [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Chiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19... [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami) [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson’s Disease [Last Updated On: August 18th, 2024] [Originally Added On: October 30th, 2020]
- Reata Pharmaceuticals, Inc. to Report Third Quarter 2020 Financial Results and Provide an Update on Development Programs on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Syneos Health to Present at Upcoming Investor Conferences [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Terranueva Announces Changes to Its Management Team [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Satsuma Pharmaceuticals to to participate in the following November Virtual Investor Conferences [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Trillium Therapeutics Announces Formation of Scientific Advisory Board [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Neuronetics Reports Third Quarter 2020 Financial and Operating Results [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020 [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review... [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]